| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sara Samadzadeh, Rafl Adnan, Paulina Berglova, Mahdi Barzegar, Birgit Debrabant, Stine Gundtoft Roikjaer, Michael Levy, Axel Petzold, Jacqueline Palace, Eoin P Flanagan, Sara Mariotto, Soeren T Skou, Anne Froelich, Itay Lotan, Silvia Messina, Ruth Geraldes, Susanna Asseyer, Hadas Stiebel-Kalish, Frederike Cosima Oertel, Vahid Shaygannejad, Mohammad Ali Sahraian, Ho Jin Kim, Jeffrey L Bennett, Chotima Böttcher, Hanna G Zimmermann, Brian G Weinshenker, Friedemann Paul, Nasrin Asgar. Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT). Frontiers in immunology. vol 15. 2024-07-18. PMID:39021565. |
comorbidities in patients with multiple sclerosis (ms) and antibody-mediated diseases of the central nervous system (cns) including neuromyelitis optica spectrum disorder (nmosd), and myelin oligodendrocyte glycoprotein (mog)-antibody-associated disease (mogad) are common and may influence the course of their neurological disease. |
2024-07-18 |
2024-07-20 |
human |
| Carson E Moseley, Akash Virupakshaiah, Thomas G Forsthuber, Lawrence Steinman, Emmanuelle Waubant, Scott S Zamvi. MOG CNS Autoimmunity and MOGAD. Neurology(R) neuroimmunology & neuroinflammation. vol 11. issue 5. 2024-07-12. PMID:38996203. |
at one time considered a possible form of neuromyelitis optica (nmo) spectrum disorder (nmosd), it is now accepted that myelin oligodendrocyte glycoprotein (mog) antibody (ab)-associated disorder (mogad) is a distinct entity from either nmo or multiple sclerosis (ms) and represents a broad spectrum of clinical phenotypes. |
2024-07-12 |
2024-07-15 |
Not clear |
| Frederick Gyabaah, Cyrena Petersen, Emily Bateman, Abhizith Deoke. Acute-Onset Blindness in a Patient Diagnosed With Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOG-AD): A Case Report. Cureus. vol 16. issue 6. 2024-07-08. PMID:38975430. |
myelin oligodendrocyte glycoprotein antibody disease (mog-ad) poses a diagnostic challenge, often masquerading as other neurological disorders such as multiple sclerosis and aquaporin-4-positive neuromyelitis optica spectrum disorder. |
2024-07-08 |
2024-07-11 |
Not clear |
| Hyunjin Ju, Yeon Hak Chung, Soonwook Kwon, Eun Bin Cho, Kyung-Ah Park, Ju-Hong Mi. Usefulness of the MFIS-K, FSS, and FACIT-F Fatigue Scales in Korean Patients With MS, NMOSD, and MOGAD. Journal of clinical neurology (Seoul, Korea). vol 20. issue 4. 2024-07-02. PMID:38951976. |
fatigue is common in demyelinating disorders of the central nervous system (cns), including multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad). |
2024-07-02 |
2024-07-04 |
Not clear |
| Tais Estrela, Hadas Stiebel-Kalish, Leigh Rettenmaier, Amanda D Henderson, Elias Sotirchos, Yana Said, Gelareh Ahmadi, Deena A Tajfirouz, Eoin P Flanagan, Nanthaya Tisavipat, Ryan Gise, Bart K Chwalisz, John J Che. Optic Disc Cupping in Neuromyelitis Optica Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, and Multiple Sclerosis and Its Relationship With Optical Coherence Tomography Parameters: A Multicenter Study. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2024-07-01. PMID:38946028. |
optic disc cupping in neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and multiple sclerosis and its relationship with optical coherence tomography parameters: a multicenter study. |
2024-07-01 |
2024-07-03 |
Not clear |
| Tais Estrela, Hadas Stiebel-Kalish, Leigh Rettenmaier, Amanda D Henderson, Elias Sotirchos, Yana Said, Gelareh Ahmadi, Deena A Tajfirouz, Eoin P Flanagan, Nanthaya Tisavipat, Ryan Gise, Bart K Chwalisz, John J Che. Optic Disc Cupping in Neuromyelitis Optica Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, and Multiple Sclerosis and Its Relationship With Optical Coherence Tomography Parameters: A Multicenter Study. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2024-07-01. PMID:38946028. |
the purpose of this study was to compare cupping in patients after on from multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), or myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) and to investigate the relationship between cupping and retinal nerve fiber layer (rnfl) and ganglion cell complex (gcc) thinning. |
2024-07-01 |
2024-07-03 |
Not clear |
| Alessandro Cagol, Charidimos Tsagkas, Cristina Granzier. Advanced Brain Imaging in Central Nervous System Demyelinating Diseases. Neuroimaging clinics of North America. vol 34. issue 3. 2024-06-28. PMID:38942520. |
this review delves into state-of-the-art modalities applied to multiple sclerosis, neuromyelitis optica spectrum disorders, and myelin oligodendrocyte glycoprotein antibody-associated disease. |
2024-06-28 |
2024-07-01 |
Not clear |
| Massimo Filippi, Paolo Preziosa, Monica Margoni, Maria A Rocc. Diagnostic Criteria for Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and Myelin Oligodendrocyte Glycoprotein-immunoglobulin G-associated Disease. Neuroimaging clinics of North America. vol 34. issue 3. 2024-06-28. PMID:38942518. |
diagnostic criteria for multiple sclerosis, neuromyelitis optica spectrum disorders, and myelin oligodendrocyte glycoprotein-immunoglobulin g-associated disease. |
2024-06-28 |
2024-07-01 |
Not clear |
| Massimo Filippi, Paolo Preziosa, Monica Margoni, Maria A Rocc. Diagnostic Criteria for Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and Myelin Oligodendrocyte Glycoprotein-immunoglobulin G-associated Disease. Neuroimaging clinics of North America. vol 34. issue 3. 2024-06-28. PMID:38942518. |
neuromyelitis optica spectrum disorders (nmosd) and myelin oligodendrocyte glycoprotein-immunoglobulin g-associated disease (mogad) are recognized as separate conditions from ms, with specific diagnostic criteria. |
2024-06-28 |
2024-07-01 |
Not clear |
| Bas Jaspers. Spinal Cord Imaging in Multiple Sclerosis and Related Disorders. Neuroimaging clinics of North America. vol 34. issue 3. 2024-06-28. PMID:38942523. |
the anatomical, pathologic, imaging and prognostic consideriations for the spinal cord for ms and the most important other demyelinating disorders, neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease, are reviewed. |
2024-06-28 |
2024-07-01 |
Not clear |
| Àlex Rovira, Angela Vidal-Jordana, Cristina Auger, Jaume Sastre-Garrig. Optic Nerve Imaging in Multiple Sclerosis and Related Disorders. Neuroimaging clinics of North America. vol 34. issue 3. 2024-06-28. PMID:38942524. |
optic neuritis is a common feature in multiple sclerosis and in 2 other autoimmune demyelinating disorders such as aquaporin-4 igg antibody-associated neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease. |
2024-06-28 |
2024-07-01 |
Not clear |
| Mark M Magharious, Melike Pekmezci, Mark D Mamlouk, Jonathan C Horton, Marc H Levi. Revised Diagnosis From Histiocytic Neoplasm to Optic Chiasm Glioblastoma After Genetic Analysis. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2024-06-27. PMID:38926909. |
serologic testing (including myelin oligodendrocyte glycoprotein and neuromyelitis optica antibodies) and cerebrospinal fluid analysis were negative. |
2024-06-27 |
2024-06-29 |
Not clear |
| János György Pitter, László Nagy, Balázs Nagy, Rok Hre. Development Perspectives for Curative Technologies in Primary Demyelinating Disorders of the Central Nervous System with Neuromyelitis Optica Spectrum Disorder (NMOSD) and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) at the Forefront. Journal of personalized medicine. vol 14. issue 6. 2024-06-27. PMID:38929820. |
development perspectives for curative technologies in primary demyelinating disorders of the central nervous system with neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) at the forefront. |
2024-06-27 |
2024-06-29 |
Not clear |
| János György Pitter, László Nagy, Balázs Nagy, Rok Hre. Development Perspectives for Curative Technologies in Primary Demyelinating Disorders of the Central Nervous System with Neuromyelitis Optica Spectrum Disorder (NMOSD) and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) at the Forefront. Journal of personalized medicine. vol 14. issue 6. 2024-06-27. PMID:38929820. |
primary demyelinating disorders of the central nervous system (cns) include multiple sclerosis and the orphan conditions neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein igg-associated disease (mogad). |
2024-06-27 |
2024-06-29 |
Not clear |
| O Fernández, X Montalbán, E Agüera, Y Aladro, A Alonso, R Arroyo, L Brieva, C Calles, L Costa-Frossard, S Eichau, J M García-Domínguez, M A Hernández, L Landete, M Llaneza, S Llufriu, J E Meca-Lallana, V Meca-Lallana, E Moral, J M Prieto, Ll Ramió-Torrentà, N Téllez, L Romero-Pinel, A Vilaseca, A Rodríguez-Antigüeda. [XVI Post-ECTRIMS Meeting: review of the new developments presented at the 2023 ECTRIMS Congress (I)]. Revista de neurologia. vol 79. issue 1. 2024-06-27. PMID:38934946. |
perspectives in demyelinating pathologies were reviewed, focusing on neuromyelitis optica and myelin oligodendrocyte glycoprotein antibody-associated disease, highlighting their pathophysiological and diagnostic differences compared to ms. advances in neuroimaging were also discussed, and especially the analysis of active chronic lesions, such as paramagnetic rim lesions. |
2024-06-27 |
2024-06-29 |
Not clear |
| Wenjing Luo, Xiaonan Zhong, Shishi Shen, Ling Fang, Yiying Huang, Yuge Wang, Wei Qi. A comparative study of hypothalamic involvement in patients with myelin oligodendrocyte glycoprotein antibody-associated disease, neuromyelitis optica spectrum disorder, and multiple sclerosis. European journal of neurology. 2024-06-12. PMID:38863307. |
a comparative study of hypothalamic involvement in patients with myelin oligodendrocyte glycoprotein antibody-associated disease, neuromyelitis optica spectrum disorder, and multiple sclerosis. |
2024-06-12 |
2024-06-14 |
Not clear |
| Wenjing Luo, Xiaonan Zhong, Shishi Shen, Ling Fang, Yiying Huang, Yuge Wang, Wei Qi. A comparative study of hypothalamic involvement in patients with myelin oligodendrocyte glycoprotein antibody-associated disease, neuromyelitis optica spectrum disorder, and multiple sclerosis. European journal of neurology. 2024-06-12. PMID:38863307. |
we aimed to characterize hypothalamic involvement in myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) and compare it with neuromyelitis optica spectrum disorder (nmosd) and multiple sclerosis (ms). |
2024-06-12 |
2024-06-14 |
Not clear |
| Yuqing Wu, Hao Zhou, Xiaojiao Ci, Jie L. Low T3 syndrome is associated with the severity of myelin oligodendrocyte glycoprotein antibody-associated disease exacerbation. Frontiers in neuroscience. vol 18. 2024-06-05. PMID:38835837. |
myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) is a rare autoimmune inflammatory disease of the central nervous system, (cns) different from multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (nmosd). |
2024-06-05 |
2024-06-07 |
Not clear |
| Caterina Lapucci, Vincenzo Daniele Boccia, Thoma Dario Clementi, Simona Schiavi, Luana Benedetti, Antonio Uccelli, Giovanni Novi, Maria Cellerino, Matilde Ingles. Brain lesion microstructure in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein disease. Journal of neuroimaging : official journal of the American Society of Neuroimaging. 2024-06-04. PMID:38831519. |
brain lesion microstructure in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein disease. |
2024-06-04 |
2024-06-06 |
Not clear |
| Caterina Lapucci, Vincenzo Daniele Boccia, Thoma Dario Clementi, Simona Schiavi, Luana Benedetti, Antonio Uccelli, Giovanni Novi, Maria Cellerino, Matilde Ingles. Brain lesion microstructure in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein disease. Journal of neuroimaging : official journal of the American Society of Neuroimaging. 2024-06-04. PMID:38831519. |
neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) diagnosis are based on the presence of serological and magnetic resonance imaging (mri) biomarkers. |
2024-06-04 |
2024-06-06 |
Not clear |